HealthQuill European Society of Cardiology
BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a rare heart disease condition has yielded positive results.
Drugs Health Pharma

BridgeBio says oral drug to treat rare heart disease meets trial goal

HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.

Read More